European Heart Journal Advance Access originally published online on January 24, 2006
European Heart Journal 2006 27(7):824-831; doi:10.1093/eurheartj/ehi749
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Coronary endothelial dysfunction is associated with erectile dysfunction and elevated asymmetric dimethylarginine in patients with early atherosclerosis


Division of Cardiovascular Disease, Nephrology, and Internal Medicine, Mayo College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
Received 21 July 2005; revised 19 December 2005; accepted 4 January 2006; online publish-ahead-of-print 24 January 2006.
* Corresponding author. E-mail address: lerman.amir{at}mayo.edu
Aims Coronary endothelial dysfunction (CED) precedes atherosclerosis and is associated with cardiovascular events. Both CED and erectile dysfunction (ED) are partly mediated by impairment in the nitric oxide pathway. ED is associated with established coronary atherosclerosis, but its relationship with early coronary atherosclerosis and CED is unknown. This study was designed to test the hypothesis that CED is associated with ED in men with early coronary atherosclerosis. Moreover, the role of the nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) was investigated; ADMA is a novel endogenous competitive inhibitor of nitric oxide synthase and has been shown to be an independent marker for cardiovascular disease.
Methods and results Fifty-six men without obstructive coronary artery disease (CAD) who underwent coronary endothelial function testing were studied. ADMA levels were determined and all men were asked to complete the International Index of Erectile Function-5 questionnaire to assess erectile function. Patients were divided according to the presence (n=32) or absence (n=24) of CED. Men with CED had significant impairment of erectile function (P=0.008) and significantly higher ADMA levels (0.50±0.06 vs. 0.45±0.07 ng/mL, P=0.017) compared with men with normal endothelial function. Erectile function positively correlated with coronary endothelial function. This correlation was independent of age, body mass index, high-density lipoprotein, C-reactive protein, homeostasis model assessment of insulin resistance index, and smoking status.
Conclusion CED is independently associated with ED and plasma ADMA concentration in men with early coronary atherosclerosis. This study further supports the role of the endothelium in systemic vascular diseases and the role of ADMA in the systemic manifestations of endothelial dysfunction.
Key Words: Erectile dysfunction Endothelial dysfunction Coronary circulation Asymmetric dimethylarginine
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. Rubinshtein, E. H. Yang, C. S. Rihal, A. Prasad, R. J. Lennon, P. J. Best, L. O. Lerman, and A. Lerman Coronary microcirculatory vasodilator function in relation to risk factors among patients without obstructive coronary disease and low to intermediate Framingham score Eur. Heart J., November 5, 2009; (2009) ehp459v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Aversa, R. Bruzziches, D. Francomano, M. Natali, and A. Lenzi Testosterone and phosphodiesterase type-5 inhibitors: new strategy for preventing endothelial damage in internal and sexual medicine? Therapeutic Advances in Urology, October 1, 2009; 1(4): 179 - 197. [Abstract] [PDF] |
||||
![]() |
C. Antoniades, C. Shirodaria, P. Leeson, A. Antonopoulos, N. Warrick, T. Van-Assche, C. Cunnington, D. Tousoulis, R. Pillai, C. Ratnatunga, et al. Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis Eur. Heart J., May 1, 2009; 30(9): 1142 - 1150. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Inman, J. L. St. Sauver, D. J. Jacobson, M. E. McGree, A. Nehra, M. M. Lieber, V. L. Roger, and S. J. Jacobsen A Population-Based, Longitudinal Study of Erectile Dysfunction and Future Coronary Artery Disease Mayo Clin. Proc., February 1, 2009; 84(2): 108 - 113. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tatematsu, S. Wakino, T. Kanda, K. Homma, K. Yoshioka, K. Hasegawa, N. Sugano, M. Kimoto, T. Saruta, and K. Hayashi Role of Nitric Oxide-Producing and -Degrading Pathways in Coronary Endothelial Dysfunction in Chronic Kidney Disease J. Am. Soc. Nephrol., March 1, 2007; 18(3): 741 - 749. [Abstract] [Full Text] [PDF] |
||||



